Feller. I copied this from elsewhere but also rea
Post# of 15624
(Total Views: 345)
Posted On: 03/10/2018 4:53:32 PM
Feller. I copied this from elsewhere but also read it myself in the 36 pages I read. Diagnose this please. These two errors are what my mind circles around. I realize in another spot it says JF also did the disbarred attorney as well for the final clearing. Also the non disclosure of why the funds were issued global ,I’ve been told should have been In the initial filing. FYI. I’m very long here and also attended the show. Thanks.
32. Pursuant to the compensation terms of the Global PR/IR Agreement, OWC transferred 5,134,375 OWC shares to Global on February 5, 2016. OWC provided an attorney opinion letter to OWC’s transfer agent from a disbarred attorney in connection with the issuance of OWC’s stock to Global. OWC disclosed in reports it filed with the SEC in February 2016 that Global owned these shares of stock – 6.3% of OWC’s common stock at that time – and that Friedland controlled them as Global’s President and CEO, but neither OWC, Friedland, nor Global made any disclosure as to how the shares were acquired by Global.
37. On November 18, 2016, OWC issued a press release via PR Newswire announcing “OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event.” The press release quoted Friedland, “There are many cannabis companies that are publicly-traded, from GW Pharmaceuticals (GWPH) to
smaller public companies such as OWC, which Intiva invested in during the summer of 2014….I joined the Company’s advisory board earlier this year.” The release continues, “Subject to his schedule, Mr. Friedland may be available to meet privately with OWC shareholders to discuss his view of OWC’s future.” Nowhere in OWC’s press release did Friedland or OWC disclose that he and Global had just been hired to handle OWC’s media and investor relations in the United States and been paid more than 5.1 million shares of OWC stock to do so.
https://businessden.com/wp-content/uploads/20...nd-SEC.pdf
32. Pursuant to the compensation terms of the Global PR/IR Agreement, OWC transferred 5,134,375 OWC shares to Global on February 5, 2016. OWC provided an attorney opinion letter to OWC’s transfer agent from a disbarred attorney in connection with the issuance of OWC’s stock to Global. OWC disclosed in reports it filed with the SEC in February 2016 that Global owned these shares of stock – 6.3% of OWC’s common stock at that time – and that Friedland controlled them as Global’s President and CEO, but neither OWC, Friedland, nor Global made any disclosure as to how the shares were acquired by Global.
37. On November 18, 2016, OWC issued a press release via PR Newswire announcing “OWC Pharmaceutical Research Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event.” The press release quoted Friedland, “There are many cannabis companies that are publicly-traded, from GW Pharmaceuticals (GWPH) to
smaller public companies such as OWC, which Intiva invested in during the summer of 2014….I joined the Company’s advisory board earlier this year.” The release continues, “Subject to his schedule, Mr. Friedland may be available to meet privately with OWC shareholders to discuss his view of OWC’s future.” Nowhere in OWC’s press release did Friedland or OWC disclose that he and Global had just been hired to handle OWC’s media and investor relations in the United States and been paid more than 5.1 million shares of OWC stock to do so.
https://businessden.com/wp-content/uploads/20...nd-SEC.pdf
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼